Endometriosis – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Sat, 25 Mar 2023 01:23:31 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Endometriosis – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model https://www.cannabisclinicians.org/2023/03/24/cannabidiol-as-a-potential-novel-treatment-for-endometriosis-by-its-anti-inflammatory-antioxidative-and-antiangiogenic-effects-in-an-experimental-rat-model/ Sat, 25 Mar 2023 01:23:31 +0000 https://www.cannabisclinicians.org/?p=28137 Endometrial implants were surgically induced in 36 female Wistar albino rats. After confirmation of endometriotic foci, the rats were randomized into four groups. In the leuprolide acetate group, rats were given a single 1 mg/kg s.c. leuprolide acetate injection. The other groups were 5 mg/kg CBD (CBD5), saline solution and 20 mg/kg CBD (CBD20); daily i.p. injections were administered for 7 days. After 21 days, the rats were euthanised, and total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) measurements in blood and peritoneal fluid samples, and immunohistochemical staining for TNF-α, IL-6 and vascular endothelial growth factor (VEGF) of endometriotic tissues were evaluated.

The post Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model appeared first on Society of Cannabis Clinicians.

]]> Is it the Ideal Time to Start Prescribing Cannabis Derivatives to Treat Endometriosis-associated Pain? https://www.cannabisclinicians.org/2023/03/10/is-it-the-ideal-time-to-start-prescribing-cannabis-derivatives-to-treat-endometriosis-associated-pain/ Sat, 11 Mar 2023 00:45:36 +0000 https://www.cannabisclinicians.org/?p=27991 Endometriosis affects 5%-10% of women of reproductive age and is often associated with painful symptoms like dysmenorrhea, dyschezia, dyspareunia, and even non cyclical pain. The disease is diagnosed in at least 20% of women with dysmenorrhea and/or non-menstrual pelvic pain, reaching a prevalence of 50% pain among adolescents. There is an alignment among international societies3,4 that the pre- sumed diagnosis of this disease is enough to start clinical treatment. Moreover, there seems to be a consensus that first-line treatment should be hormonal contraceptives since the efficacy is similar to that of surgery but with lower complication rates and costs. However, these drugs are
effective in only approximately two-thirds of patients, have limited long-term efficacy and may occasionally lead to undesirable side effects. Additionally, there are serious limitations in the interpretation of clinical trials.

The post Is it the Ideal Time to Start Prescribing Cannabis Derivatives to Treat Endometriosis-associated Pain? appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and anti-angiogenic effects in an experimental rat model https://www.cannabisclinicians.org/2023/03/04/cannabidiol-as-a-potential-novel-treatment-for-endometriosis-by-its-anti-inflammatory-antioxidative-and-anti-angiogenic-effects-in-an-experimental-rat-model/ Sat, 04 Mar 2023 14:02:47 +0000 https://www.cannabisclinicians.org/?p=27948 Can cannabidiol (CBD) be used in the treatment of endometriosis by its anti-inflammatory, antioxidative, and anti-angiogenic effects? Endometrial implants were surgically induced in 36 female Wistar-Albino rats. After confirmation of endometriotic foci, the rats were randomized into four groups. In leuprolide acetate (LA) group, rats were given a single 1mg/kg subcutaneous LA injection. Other groups were 5 mg/kg CBD (CBD5), saline solution (SS), and 20 mg/kg CBD (CBD20) and daily intra-peritoneal injections were applied for seven days. After 21 days, the rats were sacrificed, and total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) measurements in blood and peritoneal fluid samples, and immunohistochemical staining for TNF-α, IL-6 and vascular endothelial growth factor (VEGF) of endometriotic tissues were evaluated.

The post Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and anti-angiogenic effects in an experimental rat model appeared first on Society of Cannabis Clinicians.

]]> Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications https://www.cannabisclinicians.org/2022/11/05/role-of-the-endocannabinoid-system-in-the-pathophysiology-of-endometriosis-and-therapeutic-implications/ Sat, 05 Nov 2022 23:54:22 +0000 https://www.cannabisclinicians.org/?p=27119 Endometriosis patients experience debilitating chronic pain, and the first-line treatment is ineffective at managing symptoms. Although surgical removal of the lesions provides temporary relief, more than 50% of the patients experience disease recurrence. Despite being a leading cause of hysterectomy, endometriosis lacks satisfactory treatments and a cure. Another challenge is the poor understanding of disease pathophysiology which adds to the delays in diagnosis and overall compromised quality of life. Endometriosis patients are in dire need of an effective therapeutic strategy that is both economical and effective in managing symptoms, while fertility is unaffected. Endocannabinoids and phytocannabinoids possess anti-inflammatory, anti-nociceptive, and anti-proliferative properties that may prove beneficial for endometriosis management, given that inflammation, vascularization, and pain are hallmark features of endometriosis.

The post Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications appeared first on Society of Cannabis Clinicians.

]]> Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms https://www.cannabisclinicians.org/2021/11/10/effects-of-cannabis-ingestion-on-endometriosis-associated-pelvic-pain-and-related-symptoms/ Thu, 11 Nov 2021 01:03:22 +0000 https://www.cannabisclinicians.org/?p=25123 The use of cannabis for symptoms of endometriosis was investigated utilising retrospective archival data from Strainprint Technologies Ltd., a Canadian data technology company with a mobile phone application that tracks a range of data including dose, mode of administration, chemovar and their effects on various self-reported outcomes, including pelvic pain.

The post Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain https://www.cannabisclinicians.org/2021/10/20/cannabidiol-use-substitution-for-medications-and-perceptions-of-effectiveness-in-women-with-chronic-pelvic-pain/ Wed, 20 Oct 2021 17:50:04 +0000 https://www.cannabisclinicians.org/?p=24762 To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.
To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

To describe the prevalence and patterns of cannabidiol (CBD) use in women with co-existing chronic pelvic pain (CPP) and fibromyalgia, and to evaluate characteristics associated with pain improvement.

Many cannabinoids display promising non-hallucinogenic bioactivities that are determined by the variable nature of the side chain and prenyl group defined by the enzymes involved in their synthesis.

The post Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain appeared first on Society of Cannabis Clinicians.

]]> The Role of the Endocannabinoid System in Aetiopathogenesis of Endometriosis: A Potential Therapeutic Target https://www.cannabisclinicians.org/2019/11/15/the-role-of-the-endocannabinoid-system-in-aetiopathogenesis-of-endometriosis-a-potential-therapeutic-target/ Fri, 15 Nov 2019 14:11:38 +0000 https://www.cannabisclinicians.org/?p=15751 Authors: Keisuke Tanaka, Leah Mayne, Akram Khalil, David Baartz, Lars Eriksson, Sally-Anne Mortlock, et al
European Journal of Obstetrics & Gynecology and Reproductive Biology, 15 November 2019
---
Endometriosis affects a large proportion of women during their reproductive years and is associated with pain and infertility, also affecting psychological wellbeing and quality of life. The pathogenesis of the disease remains unclear, although it is believed to be multifactor...

The post The Role of the Endocannabinoid System in Aetiopathogenesis of Endometriosis: A Potential Therapeutic Target appeared first on Society of Cannabis Clinicians.

]]> The molecular connections between the cannabinoid system and endometriosis. https://www.cannabisclinicians.org/2012/12/01/the-molecular-connections-between-the-cannabinoid-system-and-endometriosis/ Sat, 01 Dec 2012 14:26:21 +0000 https://www.cannabisclinicians.org/?p=15753 Authors: A.M. Sanchez, P. Vigano, A. Mugione, P. Panina-Bordignon, M. Candiani
Molecular Human Reproduction, December 2012
---
The endocannabinoid system consists of an array of endogenously produced bioactive lipids that activate cannabinoid 1 (CB1) and 2 (CB2) receptors. Alterations of this system have been described in almost every category of disease. These changes can be protective or maladaptive...

The post The molecular connections between the cannabinoid system and endometriosis. appeared first on Society of Cannabis Clinicians.

]]> Endocannabinoid involvement in endometriosis. https://www.cannabisclinicians.org/2010/12/01/endocannabinoid-involvement-in-endometriosis/ Wed, 01 Dec 2010 14:34:46 +0000 https://www.cannabisclinicians.org/?p=15757 Authors: Natalia Dmitrieva, Hiroshi Nagabukuro, David Resuehr, Guohua Zhang, Stacy McAllister, et al
Pain, December 2010
---
Endometriosis is a disease common in women that is defined by abnormal extrauteral growths of uterine endometrial tissue and associated with severe pain. Partly because how the abnormal growths become associated with pain is poorly understood, the pain is difficult to alleviat...

The post Endocannabinoid involvement in endometriosis. appeared first on Society of Cannabis Clinicians.

]]>